Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Roche’s Avastin Remains Most Requested Drug in UK’s Cancer Drugs Fund
Aug. 31, 2012
Almost a quarter of all applications to the UK’s cancer drugs fund between April 2011 and March 2012 were for Roche’s Avastin, according to figures released by the NHS’ National Cancer Action Team (NCAT).
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing